For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online
United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Customized Products & Partnerships
    Customized Products & Partnerships

    Customized products and commercial partnerships to accelerate your diagnostic and therapeutic programs.

    Customized products

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

GAPDH: not just for glycolysis

Related

  • GAPDH resources
    • Molecular targets of glycolysis
      • Studying hallmarks of cancer
        • Loading control guide
        • Related Products
          • Anti-GAPDH antibody
            • Loading control antibody panels
              • Measure cell metabolism
                • Browse our metabolism range

                ​​Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is an enzyme involved in breaking down glucose to obtain energy.

                More specifically, in eukaryotes, this enzyme catalyzes the sixth step in glycolysis, converting glyceraldehyde 3-phosphate to D-glycerate 1,3-bisphosphate (1,3-BPG).

                After a few steps in glycolysis where no energy has been produced - in fact, two molecules of ATP are consumed in the initial steps - GAPDH is involved in the first reaction harnessing some of the energy present in glucose.

                The reaction occurs in two coupled steps: first, aldehyde is converted to a carboxylic acid in the presence of NAD+, and secondly a molecule of organic phosphate is added to this to generate the acyl-phosphate end-product.

                The reaction starts between the aldehyde and one of the sulfhydryl groups in GAPDH to form a hemithioacetal. This is followed by its deprotonation, to facilitate the transfer of the hydride ion (H-) tightly bound to GADPH to NAD+, generating NADH and a thioester intermediate. The second step involves phosphorylation of the thioester to form 1,3-BPG and a cysteine residue, but only after NADH has been replaced by a second NAD+. This positive charge helps polarize the thioester, facilitating the reaction with the phosphate group.

                The first step is thermodynamically favorable, whereas the second reaction is unfavorable. As a consequence, if these reactions occurred separately, the second stage would be extremely limiting due to a high activation energy. Instead, the key is to couple the two reactions with GAPDH, so that the energy generated by the favorable aldehyde oxidation can be used to trigger the formation of 1,3-BPG1,2 .

                ​​

                New roles for GAPDH

                Once its function was believed to have been unveiled to the last detail, GAPDH was thrown in the “housekeeping gene” list and considered devoid of any significant research impact. However, recent studies have found that GAPDH is capable of multiple functions completely unrelated to its participation in glycolysis 3. These include membrane fusion and cytoskeleton dynamics, as well as DNA repair and RNA export. Researchers believe these functions are likely to be regulated by post-translational changes and cellular localization4.

                GAPDH is found to be a sensor of intracellular and extracellular cell stress capable of activating pathways to recover from the insult or activate the cell death signaling pathways 3,4. In the cytoplasm, under normal physiological conditions, active GAPDH promotes a move from anaerobic respiration to the pentose phosphate pathway. However, under conditions of oxidative stress, this enzyme can be reversibly inactivated by S-thiolation of its sulfhydryl groups, allowing cells to switch between metabolic functions and ensure maintenance of a balanced oxidation/reduction state5. In contrast, increasing levels of GAPDH accumulating in the mitochondria can activate apoptotic mechanisms, resulting in permeabilization of the mitochondrial membrane after release of apoptosis-inducing factor and cytochrome c6.   

                These new multiple GAPDH functions, especially as they involve mechanisms leading to cell death4, may indicate that when expressed in abnormal levels this enzyme is involved in certain diseases3. There is some evidence to support this, particularly in neurodegenerative conditions. For example, increased levels of GAPDH are found in post-mortem brains of patients suffering from Parkinson’s7 and Alzheimer’s disease8. It has been tentatively suggested that GAPDH can interact with mutant huntingtin and β-amyloid peptides, respectively9,10.

                Browse all GAPDH products

                References

                • 1. Lodish H, Berk A, Zipursky S, Matsudaira P, Baltimore D and Darnell J (2000). Molecular Cell Biology (4th Edition). New York: W. H. Freeman.
                • 2. Berg JM, Tymoczko JL, Stryer L (2002). Biochemistry (5th Edition). New York: W H Freeman.
                • 3. Tristan C, Shahani N, Sedlak TW, Sawa A (2011). The diverse functions of GAPDH: views from different subcellular compartments. Cell Signal. Feb;23(2):317-23.
                • 4. Colell A, Green DR, Ricci JE (2009). Novel roles for GAPDH in cell death and carcinogenesis. Cell Death Differ. Dec;16(12):1573-81.
                • 5. Schuppe-Koistinen I, Moldéus P, Bergman T, Cotgreave IA (1994). S-thiolation of human endothelial cell glyceraldehyde-3-phosphate dehydrogenase after hydrogen peroxide treatment. Eur J Biochem. May 1;221(3):1033-7.
                • 6. Tarze A, Deniaud A, Le Bras M, Maillier E, Molle D, Larochette N, Zamzami N, Jan G, Kroemer G, Brenner C (2007). GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization. Oncogene. Apr 19;26(18):2606-20.
                • 7. Tatton NA (2000). Increased caspase-3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp Neurol. Nov;166(1):29-43.
                • 8. Tsuchiya K, Tajima H, Yamada M, Takahashi H, Kuwae T, Sunaga K, Katsube N, Ishitani R (2004). Disclosure of a pro-apoptotic glyceraldehyde-3-phosphate dehydrogenase promoter: anti-dementia drugs depress its activation in apoptosis. Life Sci. May 14;74(26):3245-58.
                • 9. Burke JR, Enghild JJ, Martin ME, Jou YS, Myers RM, Roses AD, Vance JM, Strittmatter WJ (1996). Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med. 2(3):347-50.
                • 10. Cumming RC, Schubert D (2005). Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease. FASEB J. Dec;19(14):2060-2.
                Get resources and offers direct to your inbox Sign up
                A-Z by research area
                • Cancer
                • Cardiovascular
                • Cell biology
                • Developmental biology
                • Epigenetics & Nuclear signaling
                • Immunology
                • Metabolism
                • Microbiology
                • Neuroscience
                • Signal transduction
                • Stem cells
                A-Z by product type
                • Primary antibodies
                • Secondary antibodies
                • Biochemicals
                • Isotype controls
                • Flow cytometry multi-color selector
                • Kits
                • Loading controls
                • Lysates
                • Peptides
                • Proteins
                • Slides
                • Tags and cell markers
                • Tools & Reagents
                Help & support
                • Support
                • Make an Inquiry
                • Protocols & troubleshooting
                • Placing an order
                • RabMAb products
                • Biochemical product FAQs
                • Training
                • Browse by Target
                Company
                • Corporate site
                • Investor relations
                • Company news
                • Careers
                • About us
                • Blog
                Events
                • Tradeshows
                • Conferences
                International websites
                • abcam.cn
                • abcam.co.jp

                Join with us

                • LinkedIn
                • facebook
                • Twitter
                • YouTube
                • Terms of sale
                • Website terms of use
                • Cookie policy
                • Privacy policy
                • Legal
                • Modern slavery statement
                © 1998-2022 Abcam plc. All rights reserved.